B. Metzler seel. Sohn & Co. AG Has $6.96 Million Position in CME Group Inc. $CME

Key Points

• B. Metzler seel. Sohn & Co. AG increased its stake in CME Group Inc. by 4.1% during the 1st quarter, raising its holdings to 26,228 shares worth approximately $6.96 million.
• CME Group reported a quarterly earnings per share of $2.96, exceeding analysts' expectations, with revenue of $1.69 billion, reflecting a year-over-year growth of 10.4%.
• Analysts have varied ratings on CME Group's stock, with four ratings as "Buy," nine as "Hold," and three as "Sell," and a current consensus rating of "Hold" along with an average target price of $261.93.

B. Metzler seel. Sohn & Co. AG grew its position in CME Group Inc. (NASDAQ:CME - Free Report) by 4.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,228 shares of the financial services provider's stock after purchasing an additional 1,023 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in CME Group were worth $6,958,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CME. GQG Partners LLC lifted its holdings in shares of CME Group by 7,676.3% in the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock valued at $584,975,000 after purchasing an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of CME Group by 370.5% in the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock valued at $704,068,000 after purchasing an additional 2,089,935 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of CME Group by 32,941.0% in the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after purchasing an additional 1,853,261 shares in the last quarter. Nuveen LLC bought a new stake in shares of CME Group in the first quarter valued at about $218,842,000. Finally, Egerton Capital UK LLP lifted its holdings in shares of CME Group by 79.4% in the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider's stock valued at $459,003,000 after purchasing an additional 765,773 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on CME. Piper Sandler boosted their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Citigroup upped their target price on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Barclays set a $298.00 target price on CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Finally, Oppenheimer upped their target price on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, CME Group has a consensus rating of "Hold" and an average price target of $261.93.

Insider Buying and Selling at CME Group

In other CME Group news, Director Charles P. Carey sold 500 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director directly owned 4,900 shares of the company's stock, valued at $1,300,215. This represents a 9.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director William R. Shepard acquired 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was purchased at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.30% of the company's stock.

CME Group Stock Performance

NASDAQ CME traded down $0.26 during trading on Monday, reaching $266.51. 1,562,708 shares of the company's stock were exchanged, compared to its average volume of 1,859,420. The business has a 50 day moving average price of $275.64 and a 200-day moving average price of $269.50. The stock has a market capitalization of $96.04 billion, a P/E ratio of 25.80, a PEG ratio of 4.82 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $207.75 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $2.56 earnings per share. Sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.